IL144528A0 - Cystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s-2, 8- diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid - Google Patents

Cystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s-2, 8- diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid

Info

Publication number
IL144528A0
IL144528A0 IL14452800A IL14452800A IL144528A0 IL 144528 A0 IL144528 A0 IL 144528A0 IL 14452800 A IL14452800 A IL 14452800A IL 14452800 A IL14452800 A IL 14452800A IL 144528 A0 IL144528 A0 IL 144528A0
Authority
IL
Israel
Prior art keywords
cystal
nonan
diazabicyclo
cyclopropyl
dihydro
Prior art date
Application number
IL14452800A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IL144528A0 publication Critical patent/IL144528A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL14452800A 1999-02-26 2000-02-14 Cystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s-2, 8- diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid IL144528A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19908448A DE19908448A1 (de) 1999-02-26 1999-02-26 Kristallmodifikation D von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo[4.3.0)nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino incarbonsäure
PCT/EP2000/001203 WO2000052010A1 (de) 1999-02-26 2000-02-14 Kristallmodifikation d von 8-cyan-1-cyclopropyl-7- (1s, 6s- 2,8- diazabicyclo- [4.3.0] nonan -8-yl) -6-fluor -1,4- dihydro -4-oxo -3-c hinolincarbonsäure

Publications (1)

Publication Number Publication Date
IL144528A0 true IL144528A0 (en) 2002-05-23

Family

ID=7899026

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14452800A IL144528A0 (en) 1999-02-26 2000-02-14 Cystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s-2, 8- diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid

Country Status (22)

Country Link
US (1) US6492391B1 (de)
EP (1) EP1159277A1 (de)
JP (1) JP2002538159A (de)
KR (1) KR100756474B1 (de)
CN (1) CN1217944C (de)
AU (1) AU760710B2 (de)
BR (1) BR0008520A (de)
CA (1) CA2362804A1 (de)
CZ (1) CZ20013065A3 (de)
DE (1) DE19908448A1 (de)
HK (1) HK1045158B (de)
HU (1) HUP0200053A3 (de)
IL (1) IL144528A0 (de)
NO (1) NO320314B1 (de)
NZ (1) NZ513749A (de)
PL (1) PL349394A1 (de)
RU (1) RU2248357C2 (de)
SK (1) SK11942001A3 (de)
TR (1) TR200102435T2 (de)
UA (1) UA71606C2 (de)
WO (1) WO2000052010A1 (de)
ZA (1) ZA200106050B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
DE102004015981A1 (de) * 2004-04-01 2005-10-20 Bayer Healthcare Ag Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
SG11201907073TA (en) 2017-02-13 2019-08-27 Bayer Animal Health Gmbh Liquid composition containing pradofloxacin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676521B2 (ja) 1988-03-22 1997-11-17 北陸製薬株式会社 キノロンカルボン酸化合物ｉ型結晶の製造法
CA2201735A1 (en) 1994-11-18 1996-05-30 The Upjohn Company A new physically stable solid form of a fluoroquinolone
BR9707606B1 (pt) * 1996-02-23 2010-08-10 ácidos 8-ciano-1-ciclopropil-7-(2,8-diazabiciclo(4.3.0) nonan-8-il)-6-flúor-1,4-diidro-4-oxo-3-quinolinocarbo xìlicos, bem como medicamentos que os compreendem.
DE19854356A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation A von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-/4.3.0/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19854355A1 (de) 1998-11-25 2000-05-31 Bayer Ag Kristallmodifikation B von 8-Cyan-1-cyclopropyl-7-(1S, 6S-2,8-diazabicyclo-/4.3.O/nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure
DE19908449A1 (de) 1999-02-26 2000-08-31 Bayer Ag Kristallmodifikation C von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicylo-[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chino/incarbonsäure
JP2001242582A (ja) * 2000-02-25 2001-09-07 Fuji Photo Film Co Ltd ハロゲン化銀写真感光材料およびその現像処理方法

Also Published As

Publication number Publication date
KR100756474B1 (ko) 2007-09-07
CN1217944C (zh) 2005-09-07
BR0008520A (pt) 2001-12-18
HK1045158B (zh) 2006-04-21
WO2000052010A1 (de) 2000-09-08
TR200102435T2 (tr) 2002-01-21
RU2248357C2 (ru) 2005-03-20
JP2002538159A (ja) 2002-11-12
EP1159277A1 (de) 2001-12-05
HUP0200053A3 (en) 2003-01-28
HK1045158A1 (en) 2002-11-15
NO20014059D0 (no) 2001-08-21
SK11942001A3 (sk) 2001-12-03
DE19908448A1 (de) 2000-08-31
ZA200106050B (en) 2002-07-24
PL349394A1 (en) 2002-07-15
UA71606C2 (uk) 2004-12-15
HUP0200053A2 (hu) 2002-05-29
AU760710B2 (en) 2003-05-22
NO20014059L (no) 2001-08-21
US6492391B1 (en) 2002-12-10
CZ20013065A3 (cs) 2002-01-16
CA2362804A1 (en) 2000-09-08
NZ513749A (en) 2003-10-31
NO320314B1 (no) 2005-11-21
CN1341116A (zh) 2002-03-20
AU3154400A (en) 2000-09-21
KR20010093300A (ko) 2001-10-27

Similar Documents

Publication Publication Date Title
HK1043124A1 (en) Salt of naphthyridine carboxylic acid derivative.
ZA982335B (en) Salt of naphthyridine carboxylic acid derivative.
IL148738A0 (en) Quinoline and naphthyridine carboxylic acid antibacterials
PL347785A1 (en) Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid
IL144528A0 (en) Cystal modification d of 8-cyano-1-cyclopropyl-7- (1s, 6s-2, 8- diazabicyclo-[4.3.0] nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
AU7940598A (en) Quinolone carboxylic acid derivatives
HK1104537A1 (en) Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8- diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid
ZA200201779B (en) Intermediates for the production of quinolone carboxylic acid derivatives.
PL347799A1 (en) Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
MY125309A (en) Process for production of naphthyridine-3-carboxylic acid derivatives
HUP0200006A3 (en) Crystal modification c of 8-cyano-1-cyclopropyl-7- (1s, 6s-2,8-diazabicyclo - [4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid process for their preparation, pharmaceutical composition comprising thereof and their use
PL347786A1 (en) Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid
HUP0700056A3 (en) Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
ZA994814B (en) Process for preparing quinolone and naphthyridone carboxylic acids.
GB9907082D0 (en) The preparation of carboxylic acid derivatives
ZA200202187B (en) Quinoline and naphthyridine carboxylic acid antibacterials.
HUP9903278A3 (en) Quinolone carboxylic acids substituted by 7-(3-vinyl-1,4-piperazine-1-yl)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees